Baldwin Wealth Partners’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4
| Closed | -$216 | – | 1102 |
|
|
2024
Q2 | $216 | Buy |
+4
| New | +$216 | ﹤0.01% | 754 |
|
|
2022
Q4 | – | Sell |
-153
| Closed | -$10K | – | 787 |
|
|
2022
Q3 | $10K | Hold |
153
| – | – | ﹤0.01% | 518 |
|
|
2022
Q2 | $9K | Sell |
153
-40
| -21% | -$2.35K | ﹤0.01% | 540 |
|
|
2022
Q1 | $12K | Buy |
193
+46
| +31% | +$2.86K | ﹤0.01% | 521 |
|
|
2021
Q4 | $11K | Sell |
147
-250
| -63% | -$18.7K | ﹤0.01% | 497 |
|
|
2021
Q3 | $44K | Buy |
397
+39
| +11% | +$4.32K | ﹤0.01% | 363 |
|
|
2021
Q2 | $57K | Buy |
358
+40
| +13% | +$6.37K | 0.01% | 340 |
|
|
2021
Q1 | $38K | Buy |
318
+250
| +368% | +$29.9K | ﹤0.01% | 373 |
|
|
2020
Q4 | $10K | Hold |
68
| – | – | ﹤0.01% | 451 |
|
|
2020
Q3 | $6K | Hold |
68
| – | – | ﹤0.01% | 459 |
|
|
2020
Q2 | $5K | Hold |
68
| – | – | ﹤0.01% | 470 |
|
|
2020
Q1 | $3K | Hold |
68
| – | – | ﹤0.01% | 491 |
|
|
2019
Q4 | $4K | Buy |
+68
| New | +$4K | ﹤0.01% | 488 |
|